trial · primary record
Abemaciclib
Anatomic Stage I Breast Cancer AJCC v8
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2024-12-26 |
| Primary endpoint | Number of Patients Who Have a CD8/FOXP3 Ratio = 1.6 |
| Registry ID | NCT03979508 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:25.200Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03979508
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Abemaciclib · approval
- Abemaciclib · compound